TrialThe Journal of infectious diseases2015

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.

Todd T Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.